Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ron Ram
24 years of experience
Clinic is certified :
Allogenic bone marrow transplantation from a related donor in Israel typically costs from $142,000 to $185,000. The final price depends on the hospital choice, the complexity of the conditioning regimen, and required isolation time. In the US, similar procedures cost around $525,000 on average. Patients save around 69% compared to US prices. Standard programs in Israel include diagnostic HLA typing, high-dose chemotherapy, the transplant procedure, and extensive post-operative monitoring in specialized isolation wards.
Bookimed Expert Insight: Choosing Israel for bone marrow transplantation offers access to world-renowned experts like Professor Polina Stepensky at Hadassah Medical Center. She has performed over 3,500 successful transplants. While prices in Tel Aviv hubs like Sourasky Medical Center (Ichilov) are higher, they offer 90% oncology success rates and Joint Commission International (JCI) accreditation. For complex cases, the investment in Israeli expertise is justified by the presence of board-certified directors who have completed fellowships at top US institutions.
Why do patients choose Israel for allogenic bone marrow transplantation from a related donor?
Access advanced Allogenic bone marrow transplantation from a related donor solutions in trusted clinics .
| Israel | Turkey | Austria | |
| Allogenic bone marrow transplantation from a related donor | from $142,000 | from $67,500 | from $150,000 |
Day 1
Day 2 to 3
Day 4
Day 5
Day 6 to Week 2
Week 3 to 8
Week 8 onwards
Please note that this schedule may vary depending on individual patient conditions and recovery progress.
As the leading global medical tourism platform, we have a huge responsibility before our clients — both patients and medical centers. All the information provided on Bookimed.com related to Allogenic bone marrow transplantation from a related donor in Israel is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services related to Allogenic bone marrow transplantation from a related donor in Israel there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic related to Allogenic bone marrow transplantation from a related donor in Israel — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com related to Allogenic bone marrow transplantation from a related donor in Israel, you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information related to Allogenic bone marrow transplantation from a related donor in Israel, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform related to Allogenic bone marrow transplantation from a related donor in Israel is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com related to Allogenic bone marrow transplantation from a related donor in Israel, please feel free to contact us at
Dr. Ram Ron specializes in allogenic bone marrow transplantation from related donors at Sourasky Medical Center (Ichilov).
Several hundred stem cell transplants performed – Dr. Ron Ram specializes in bone marrow transplantation at Sourasky Medical Center.
300+ bone marrow transplants performed – Dr. El Hasid leads pediatric transplants at Dana Dwek Children's Hospital.
Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.
This procedure involves transferring healthy stem cells from a closely matched family member to replace damaged bone marrow in patients with certain diseases.
Potential risks of allogenic bone marrow transplantation in Israel include Graft-Versus-Host Disease (GVHD), severe infections due to immunosuppression, and organ damage from conditioning chemotherapy. Specialist centers like Sheba Medical Center utilize precise donor matching and Joint Commission International (JCI) protocols to mitigate these complexities during the 30-day hospital stay.
Bookimed Expert Insight: Israeli centers like Sheba and Sourasky differentiate themselves through high-volume expertise; for instance, Dr. Polina Stepensky has performed over 3,500 transplants. Data indicates that clinics with in-house CAR-T manufacturing and JCI accreditation offer a significant safety net for managing complex post-transplant immune responses.
Patient Consensus: GVHD remains the primary practical concern for many, though donor matching helps. Vigilance regarding the donor's infection status, particularly for CMV, is vital immediately before the procedure.
Allogeneic bone marrow transplant from a related donor uses healthy stem cells from a family member, like a sibling or parent, to replace diseased marrow. This procedure treats blood cancers and immune disorders, offering high engraftment success through closer Human Leukocyte Antigen (HLA) matching.
Bookimed Expert Insight: While full matches are ideal, Israel centers like Sourasky lead in haploidentical transplants. These half-matched procedures allow parents or children to serve as donors quickly. Doctors like Ronit El Hasid have performed over 300 successful transplantations using these advanced matching techniques.
Patient Consensus: Isolation is a clinical necessity involving a strict clean-room lifestyle without pets or plants. Patients often note that mild skin irritation after the procedure serves as a positive sign of the new immune system working.
Related donors are preferred because siblings share a 25% chance of providing a perfect HLA match. This close genetic compatibility significantly lowers the risk of graft-versus-host disease (GVHD). Additionally, family donors are readily available, enabling faster transplant scheduling compared to the months-long search for unrelated matches.
Bookimed Expert Insight: Israeli centers like Sheba Medical Center often leverage specific genetic heritage for better matches. While a related donor is ideal, experts like Dr. Polina Stepensky at Hadassah have performed over 3,500 transplants, frequently utilizing haploidentical (half-match) family members when a full sibling match is unavailable to avoid dangerous delays.
Patient Consensus: Patients find that family donors provide emotional reliability and are far more accessible for the urgent scheduling required in advanced hematology cases.
Doctors select the best related donor by evaluating Human Leukocyte Antigen (HLA) markers to ensure genetic compatibility. Full siblings are the primary choice due to a 25% chance of a perfect 10/10 match, which minimizes graft-versus-host disease (GVHD) and promotes successful engraftment.
Bookimed Expert Insight: Israeli centers like Sheba Medical Center often utilize in-house CAR-T manufacturing and precision PET/CT protocols alongside transplants. This integration allows surgeons like Amos Toren to manage high-risk cases where only haploidentical matches are available. If a perfect sibling match is not found, these advanced biological protocols significantly improve success rates for half-match transplants.
Patient Consensus: Patients emphasize that HLA testing for all siblings should happen immediately, as DNA similarity does not guarantee a match. They often note that urgent medical timelines may require accepting a 5/10 match over waiting for a perfect one.
Finding a suitable bone marrow donor in Israel involves rigorous genetic testing of siblings and relatives for Human Leukocyte Antigen (HLA) markers. JCI-accredited clinics like Sheba Medical Center prioritize related matches, though they also facilitate haploidentical (half-match) transplants when a full genetic match is unavailable.
Bookimed Expert Insight: While patients often focus on finding a 100% match, Sheba Medical Center data shows that their specialized CAR-T and haploidentical protocols provide high success rates even with partial matches. This flexibility is vital for patients with rare HLA types who cannot find perfect relatives.
Patient Consensus: Test all siblings immediately because genetic compatibility, not just family ties, determines success. Understand that donors can opt out at any stage, so having backup options is essential for safety.